These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 210164)

  • 21. Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.
    Aggerbeck M; Guellaen G; Hanoune J
    Br J Pharmacol; 1978 Apr; 62(4):543-8. PubMed ID: 26446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alpha-adrenergic mediated effect in rat liver. Correlation between [3H]-dihydroergocryptine binding to plasma membranes and glycogen phosphorylase activation in isolated hepatocytes.
    Aggerbeck M; Guellaen G; Hanoune J
    Biochem Pharmacol; 1980 Jun; 29(12):1653-62. PubMed ID: 6250542
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of adrenergic stimulation of hepatic adenylate cyclase by divalent cations.
    Jackowski MM; Johnson RA; Exton JH
    Biochim Biophys Acta; 1982 Jan; 714(1):74-83. PubMed ID: 6275906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist versus antagonist binding to alpha-adrenergic receptors.
    Hoffman BB; Michel T; Kilpatrick DM; Lefkowitz RJ; Tolbert ME; Gilman H; Fain JN
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4569-73. PubMed ID: 6107908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. alpha 1-Adrenergic receptors of a smooth muscle cell line: guanine nucleotides do not regulate agonist affinities.
    Cornett LE; Ball DW; Norris JS
    J Recept Res; 1981-1982; 2(5-6):601-15. PubMed ID: 6130152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydroergocryptine: a "pseudo-irreversible" alpha-adrenergic antagonist in the guinea pig vas deferens.
    Wilberding CA; Marks BH
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):387-401. PubMed ID: 6265988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in alpha-adrenergic receptors in dog livers during endotoxic shock.
    Ghosh S; Liu MS
    J Surg Res; 1983 Mar; 34(3):239-45. PubMed ID: 6300552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization by [3H]dihydroergocryptine binding of alpha-adrenergic receptors in neuroblastoma X glioma hybrid cells.
    Haga T; Haga K
    J Neurochem; 1981 Mar; 36(3):1152-9. PubMed ID: 6110704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes.
    Kawai Y; Powell A; Arinze IJ
    J Clin Endocrinol Metab; 1986 May; 62(5):827-32. PubMed ID: 3007555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydroergocryptine binding sites in bovine and rat pineal glands.
    Vacas MI; Lowenstein PR; Cardinali DP
    J Auton Nerv Syst; 1980 Dec; 2(4):305-13. PubMed ID: 6265538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro determination of the ability of drugs to bind to adrenergic receptors.
    Neufeld AH; Page ED
    Invest Ophthalmol Vis Sci; 1977 Dec; 16(12):1118-24. PubMed ID: 200584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.
    Guicheney P; Meyer P
    Br J Pharmacol; 1981 May; 73(1):33-9. PubMed ID: 6269682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the alpha 1-adrenergic receptor subtype in a smooth muscle cell line.
    Cornett LE; Norris JS
    J Biol Chem; 1982 Jan; 257(2):694-7. PubMed ID: 6119313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defect in the adrenergic receptor-adenylate cyclase system during development of catecholamine-induced cardiomyopathy.
    Corder DW; Heyliger CE; Beamish RE; Dhalla NS
    Am Heart J; 1984 Mar; 107(3):537-42. PubMed ID: 6229991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. K+ release from rat parotid cells: an alpha 1-adrenergic mediated event.
    Ito H; Hoopes MT; Baum BJ; Roth GS
    Biochem Pharmacol; 1982 Feb; 31(4):567-73. PubMed ID: 6279109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of beta-adrenergic-agonist binding to rat adipocyte membranes. Evidence that (+/-)-[3H]hydroxybenzylisoproterenol interacts selectively with the adipocyte beta-adrenergic receptors.
    Giudicelli Y; Lacasa D; Agli B
    Biochim Biophys Acta; 1982 Mar; 715(1):105-15. PubMed ID: 6122470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [3H]Dihydroergocryptine binding to alpha adrenergic receptors in canine aortic membranes.
    Tsai BS; Lefkowitz RJ
    J Pharmacol Exp Ther; 1978 Mar; 204(3):606-14. PubMed ID: 24730
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding.
    Alexander RW; Williams LT; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1564-8. PubMed ID: 1055427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of alpha-adrenergic receptors in guinea-pig vas deferens by [3H]dihydroergocryptine binding.
    Holck MI; Marks BH; Wilberding CA
    Mol Pharmacol; 1979 Jul; 16(1):77-90. PubMed ID: 225655
    [No Abstract]   [Full Text] [Related]  

  • 40. Hormone action at the membrane level. VIII. Adrenergic receptors in rat heart and adipocytes and their modulation by thyroxine.
    Ciaraldi TP; Marinetti GV
    Biochim Biophys Acta; 1978 Jul; 541(3):334-46. PubMed ID: 149563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.